

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 5.07279585 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.40975091 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.40975091 |
| 4 | cysteine metabolic process (GO:0006534) | 4.40377830 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.33734704 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.22253530 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.22253530 |
| 8 | short-chain fatty acid metabolic process (GO:0046459) | 4.15168187 |
| 9 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99359634 |
| 10 | lysine catabolic process (GO:0006554) | 3.90983510 |
| 11 | lysine metabolic process (GO:0006553) | 3.90983510 |
| 12 | fatty acid beta-oxidation (GO:0006635) | 3.89646471 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 3.83606450 |
| 14 | glutamate metabolic process (GO:0006536) | 3.78984802 |
| 15 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74061285 |
| 16 | lipid oxidation (GO:0034440) | 3.70640780 |
| 17 | fatty acid oxidation (GO:0019395) | 3.68963934 |
| 18 | positive regulation of fatty acid oxidation (GO:0046321) | 3.68018874 |
| 19 | valine metabolic process (GO:0006573) | 3.68017821 |
| 20 | biotin metabolic process (GO:0006768) | 3.65079813 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 3.56585522 |
| 22 | low-density lipoprotein particle clearance (GO:0034383) | 3.55540527 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 3.53172250 |
| 24 | fatty acid catabolic process (GO:0009062) | 3.52922565 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 3.51903865 |
| 26 | succinate metabolic process (GO:0006105) | 3.50676486 |
| 27 | fatty acid homeostasis (GO:0055089) | 3.43807019 |
| 28 | acetyl-CoA metabolic process (GO:0006084) | 3.37633281 |
| 29 | branched-chain amino acid catabolic process (GO:0009083) | 3.35183267 |
| 30 | triglyceride catabolic process (GO:0019433) | 3.35083329 |
| 31 | monocarboxylic acid catabolic process (GO:0072329) | 3.35048326 |
| 32 | neutral lipid catabolic process (GO:0046461) | 3.34835166 |
| 33 | acylglycerol catabolic process (GO:0046464) | 3.34835166 |
| 34 | acyl-CoA biosynthetic process (GO:0071616) | 3.33729479 |
| 35 | thioester biosynthetic process (GO:0035384) | 3.33729479 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 3.32741894 |
| 37 | very long-chain fatty acid metabolic process (GO:0000038) | 3.31173675 |
| 38 | dicarboxylic acid catabolic process (GO:0043649) | 3.29949061 |
| 39 | branched-chain amino acid metabolic process (GO:0009081) | 3.27756617 |
| 40 | glyoxylate metabolic process (GO:0046487) | 3.24121817 |
| 41 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.24119821 |
| 42 | cellular modified amino acid catabolic process (GO:0042219) | 3.23604654 |
| 43 | carnitine metabolic process (GO:0009437) | 3.23143089 |
| 44 | bile acid biosynthetic process (GO:0006699) | 3.22341365 |
| 45 | regulation of sequestering of triglyceride (GO:0010889) | 3.22047798 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 3.21388104 |
| 47 | reverse cholesterol transport (GO:0043691) | 3.21372633 |
| 48 | positive regulation of lipid catabolic process (GO:0050996) | 3.20655173 |
| 49 | cellular amino acid catabolic process (GO:0009063) | 3.17899023 |
| 50 | regulation of cholesterol homeostasis (GO:2000188) | 3.17234049 |
| 51 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.16820629 |
| 52 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.14795910 |
| 53 | tricarboxylic acid metabolic process (GO:0072350) | 3.13003943 |
| 54 | triglyceride biosynthetic process (GO:0019432) | 3.11589351 |
| 55 | purine nucleotide transport (GO:0015865) | 3.11485170 |
| 56 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.10604921 |
| 57 | regulation of fatty acid oxidation (GO:0046320) | 3.09531798 |
| 58 | ethanol oxidation (GO:0006069) | 3.09199383 |
| 59 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.08749568 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.08177934 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 3.08135517 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.08042168 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08003798 |
| 64 | neutral lipid biosynthetic process (GO:0046460) | 3.07794823 |
| 65 | acylglycerol biosynthetic process (GO:0046463) | 3.07794823 |
| 66 | presynaptic membrane assembly (GO:0097105) | 3.05997461 |
| 67 | fructose metabolic process (GO:0006000) | 3.03662556 |
| 68 | carboxylic acid catabolic process (GO:0046395) | 3.03588466 |
| 69 | organic acid catabolic process (GO:0016054) | 3.03588466 |
| 70 | high-density lipoprotein particle remodeling (GO:0034375) | 3.03030779 |
| 71 | hormone catabolic process (GO:0042447) | 3.01958399 |
| 72 | plasma lipoprotein particle remodeling (GO:0034369) | 3.01845928 |
| 73 | protein-lipid complex remodeling (GO:0034368) | 3.01845928 |
| 74 | macromolecular complex remodeling (GO:0034367) | 3.01845928 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.00647762 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.00184358 |
| 77 | indole-containing compound catabolic process (GO:0042436) | 2.99787536 |
| 78 | indolalkylamine catabolic process (GO:0046218) | 2.99787536 |
| 79 | tryptophan catabolic process (GO:0006569) | 2.99787536 |
| 80 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.99074882 |
| 81 | flavonoid metabolic process (GO:0009812) | 2.99062758 |
| 82 | regulation of cholesterol metabolic process (GO:0090181) | 2.97062500 |
| 83 | adenine nucleotide transport (GO:0051503) | 2.95891967 |
| 84 | presynaptic membrane organization (GO:0097090) | 2.94147780 |
| 85 | linoleic acid metabolic process (GO:0043651) | 2.93431555 |
| 86 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.92447374 |
| 87 | triglyceride metabolic process (GO:0006641) | 2.91762102 |
| 88 | acylglycerol homeostasis (GO:0055090) | 2.90056865 |
| 89 | triglyceride homeostasis (GO:0070328) | 2.90056865 |
| 90 | L-amino acid import (GO:0043092) | 2.88198940 |
| 91 | fatty acid transmembrane transport (GO:1902001) | 2.88080266 |
| 92 | thioester metabolic process (GO:0035383) | 2.86676886 |
| 93 | acyl-CoA metabolic process (GO:0006637) | 2.86676886 |
| 94 | alanine transport (GO:0032328) | 2.86279608 |
| 95 | lipid particle organization (GO:0034389) | 2.86273209 |
| 96 | postsynaptic membrane organization (GO:0001941) | 2.85810407 |
| 97 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.83853414 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 2.83740932 |
| 99 | tryptophan metabolic process (GO:0006568) | 2.83238674 |
| 100 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.82475104 |
| 101 | phospholipid homeostasis (GO:0055091) | 2.81472285 |
| 102 | C4-dicarboxylate transport (GO:0015740) | 2.80948233 |
| 103 | homocysteine metabolic process (GO:0050667) | 2.80928407 |
| 104 | low-density lipoprotein particle remodeling (GO:0034374) | 2.80604615 |
| 105 | response to methylmercury (GO:0051597) | 2.80221382 |
| 106 | response to dietary excess (GO:0002021) | 2.80070599 |
| 107 | glycerolipid catabolic process (GO:0046503) | 2.79749164 |
| 108 | diacylglycerol metabolic process (GO:0046339) | 2.79177474 |
| 109 | kynurenine metabolic process (GO:0070189) | 2.79161466 |
| 110 | serine family amino acid catabolic process (GO:0009071) | 2.79010737 |
| 111 | nucleobase catabolic process (GO:0046113) | 2.78530365 |
| 112 | complement activation, alternative pathway (GO:0006957) | 2.78497764 |
| 113 | coenzyme catabolic process (GO:0009109) | 2.77185573 |
| 114 | axonal fasciculation (GO:0007413) | 2.73005759 |
| 115 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.69440008 |
| 116 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.66060275 |
| 117 | dendritic spine morphogenesis (GO:0060997) | 2.63027998 |
| 118 | axon ensheathment in central nervous system (GO:0032291) | 2.59502341 |
| 119 | central nervous system myelination (GO:0022010) | 2.59502341 |
| 120 | brown fat cell differentiation (GO:0050873) | 2.59451350 |
| 121 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.57952933 |
| 122 | neuron recognition (GO:0008038) | 2.54398209 |
| 123 | vocalization behavior (GO:0071625) | 2.53303415 |
| 124 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46520615 |
| 125 | cholesterol biosynthetic process (GO:0006695) | 2.45505739 |
| 126 | glycerol metabolic process (GO:0006071) | 2.44005890 |
| 127 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.43116850 |
| 128 | retinol metabolic process (GO:0042572) | 2.42815568 |
| 129 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.41359602 |
| 130 | L-serine transport (GO:0015825) | 2.40287301 |
| 131 | response to phenylpropanoid (GO:0080184) | 2.38759010 |
| 132 | auditory behavior (GO:0031223) | 2.35095595 |
| 133 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.34489374 |
| 134 | sterol biosynthetic process (GO:0016126) | 2.33284640 |
| 135 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.32692802 |
| 136 | synaptic vesicle maturation (GO:0016188) | 2.32111322 |
| 137 | white fat cell differentiation (GO:0050872) | 2.31895648 |
| 138 | primary alcohol metabolic process (GO:0034308) | 2.30868623 |
| 139 | transmission of nerve impulse (GO:0019226) | 2.29370001 |
| 140 | negative regulation of lipase activity (GO:0060192) | 2.27215071 |
| 141 | neuron cell-cell adhesion (GO:0007158) | 2.25913560 |
| 142 | neurotransmitter catabolic process (GO:0042135) | 2.25462956 |
| 143 | detection of calcium ion (GO:0005513) | 2.24038996 |
| 144 | response to nitrosative stress (GO:0051409) | 2.22107268 |
| 145 | peroxisome fission (GO:0016559) | 2.21452316 |
| 146 | positive regulation of glycolytic process (GO:0045821) | 2.20712835 |
| 147 | neuronal action potential propagation (GO:0019227) | 2.17726308 |
| 148 | neuronal ion channel clustering (GO:0045161) | 2.17099422 |
| 149 | behavioral response to nicotine (GO:0035095) | 2.16937482 |
| 150 | regulation of synapse structural plasticity (GO:0051823) | 2.16494094 |
| 151 | short-term memory (GO:0007614) | 2.14696951 |
| 152 | cGMP-mediated signaling (GO:0019934) | 2.12588627 |
| 153 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.12579730 |
| 154 | alditol metabolic process (GO:0019400) | 2.12180357 |
| 155 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.10614023 |
| 156 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.09751466 |
| 157 | fatty acid elongation (GO:0030497) | 2.06936326 |
| 158 | glutamate secretion (GO:0014047) | 2.06717258 |
| 159 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.04293539 |
| 160 | cellular potassium ion homeostasis (GO:0030007) | 2.03757203 |
| 161 | response to auditory stimulus (GO:0010996) | 2.03235901 |
| 162 | cochlea development (GO:0090102) | 2.02778225 |
| 163 | retinal ganglion cell axon guidance (GO:0031290) | 2.02449263 |
| 164 | nonmotile primary cilium assembly (GO:0035058) | 2.01066360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.63772216 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.63286863 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.08784989 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42414804 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.31101605 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.84031187 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.73036327 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.66197177 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27912620 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.26828174 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.18709712 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.03020524 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.86815311 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.84337883 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.81524545 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80937807 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.80543979 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80368922 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79390497 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66685671 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62810514 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.61830836 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61697240 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60906482 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.59880707 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58871484 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58353839 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56228315 |
| 29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55673772 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55318195 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55318195 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.53762274 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47727808 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47530454 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.46736024 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46256985 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45245823 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44735164 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44378320 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43179611 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41958737 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40392701 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39392022 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39371226 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36086302 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.32885455 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32625536 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31070429 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30442394 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30134861 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29219020 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28247535 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27935905 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25497188 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23120066 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.22922680 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22332236 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21892945 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20342175 |
| 60 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19783996 |
| 61 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15540500 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14737545 |
| 63 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14198287 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13451128 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13392335 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12272706 |
| 67 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.11450744 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10368262 |
| 69 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09540561 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.08876417 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07930909 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07401926 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07241198 |
| 74 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06228482 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06164036 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04420870 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03900140 |
| 78 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03334837 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01842277 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01174304 |
| 81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00724045 |
| 82 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00499811 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00002521 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00002521 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99835257 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99709548 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99192568 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99179359 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98349657 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98317148 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97945862 |
| 92 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97611554 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96603522 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96348184 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95927172 |
| 96 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.95850542 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95827623 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95783966 |
| 99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94555869 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94159422 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94010199 |
| 102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93342168 |
| 103 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93148057 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93138519 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93138519 |
| 106 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92641507 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92073123 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91915032 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90251760 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90007104 |
| 111 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89876063 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88785602 |
| 113 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.88671003 |
| 114 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88542277 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87909910 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87411933 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87290425 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87133599 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86976051 |
| 120 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83080740 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82500242 |
| 122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82353904 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81842753 |
| 124 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80778489 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80737462 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78877193 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78870141 |
| 128 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78773133 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.78659615 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77685758 |
| 131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.76239874 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76053642 |
| 133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75967387 |
| 134 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75804554 |
| 135 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75451705 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74531928 |
| 137 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.74172340 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.73985399 |
| 139 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72959480 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.72441443 |
| 141 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.71844878 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.71331187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.52072517 |
| 2 | MP0005360_urolithiasis | 4.74169309 |
| 3 | MP0005365_abnormal_bile_salt | 4.10915720 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.51329798 |
| 5 | MP0010329_abnormal_lipoprotein_level | 3.34704794 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23317004 |
| 7 | MP0005670_abnormal_white_adipose | 2.87829526 |
| 8 | MP0005332_abnormal_amino_acid | 2.84559171 |
| 9 | MP0004130_abnormal_muscle_cell | 2.54800758 |
| 10 | MP0003880_abnormal_central_pattern | 2.48612277 |
| 11 | MP0003122_maternal_imprinting | 2.38743206 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.22127527 |
| 13 | MP0002118_abnormal_lipid_homeostasis | 2.16573750 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.04274555 |
| 15 | MP0003252_abnormal_bile_duct | 2.02077222 |
| 16 | MP0003690_abnormal_glial_cell | 1.98487672 |
| 17 | MP0003136_yellow_coat_color | 1.97169648 |
| 18 | MP0003195_calcinosis | 1.91906610 |
| 19 | MP0004043_abnormal_pH_regulation | 1.87271161 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 1.81295545 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.81026986 |
| 22 | MP0004147_increased_porphyrin_level | 1.79625850 |
| 23 | MP0002971_abnormal_brown_adipose | 1.74267277 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.74069508 |
| 25 | MP0000778_abnormal_nervous_system | 1.72748095 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.71088949 |
| 27 | MP0003329_amyloid_beta_deposits | 1.69154097 |
| 28 | MP0004185_abnormal_adipocyte_glucose | 1.67959977 |
| 29 | MP0005535_abnormal_body_temperature | 1.67610388 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.66653635 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.65996359 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60412377 |
| 33 | MP0004885_abnormal_endolymph | 1.59856169 |
| 34 | MP0000566_synostosis | 1.57342181 |
| 35 | MP0003011_delayed_dark_adaptation | 1.55265759 |
| 36 | MP0003186_abnormal_redox_activity | 1.53508540 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.52192414 |
| 38 | MP0009840_abnormal_foam_cell | 1.51174319 |
| 39 | MP0003283_abnormal_digestive_organ | 1.49243341 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.49005620 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.44501107 |
| 42 | MP0005083_abnormal_biliary_tract | 1.41797537 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.41266356 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.38822290 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.38232917 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.36043592 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.35909442 |
| 48 | MP0000609_abnormal_liver_physiology | 1.35074781 |
| 49 | MP0002938_white_spotting | 1.30458521 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.29018355 |
| 51 | MP0002254_reproductive_system_inflammat | 1.23144342 |
| 52 | MP0001529_abnormal_vocalization | 1.22843396 |
| 53 | MP0003787_abnormal_imprinting | 1.19739183 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.16201720 |
| 55 | MP0005334_abnormal_fat_pad | 1.15969074 |
| 56 | MP0003121_genomic_imprinting | 1.15968985 |
| 57 | MP0003635_abnormal_synaptic_transmissio | 1.15589829 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.14787621 |
| 59 | MP0004924_abnormal_behavior | 1.14787621 |
| 60 | MP0001486_abnormal_startle_reflex | 1.14160446 |
| 61 | MP0003878_abnormal_ear_physiology | 1.13782838 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 1.13782838 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.13765020 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.13064431 |
| 65 | MP0004270_analgesia | 1.12469396 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.12179284 |
| 67 | MP0003633_abnormal_nervous_system | 1.10410001 |
| 68 | MP0001764_abnormal_homeostasis | 1.10100735 |
| 69 | MP0000604_amyloidosis | 1.09436422 |
| 70 | MP0009745_abnormal_behavioral_response | 1.08782540 |
| 71 | MP0004858_abnormal_nervous_system | 1.07614115 |
| 72 | MP0002090_abnormal_vision | 1.05025497 |
| 73 | MP0003868_abnormal_feces_composition | 1.04908709 |
| 74 | MP0004133_heterotaxia | 1.04474362 |
| 75 | MP0002064_seizures | 1.04310769 |
| 76 | MP0005448_abnormal_energy_balance | 1.03929624 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.03853351 |
| 78 | MP0005647_abnormal_sex_gland | 1.01942384 |
| 79 | MP0002063_abnormal_learning/memory/cond | 0.99705284 |
| 80 | MP0009115_abnormal_fat_cell | 0.99660141 |
| 81 | MP0009046_muscle_twitch | 0.99575875 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.99389933 |
| 83 | MP0005253_abnormal_eye_physiology | 0.99052343 |
| 84 | MP0001756_abnormal_urination | 0.98410463 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.98311592 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.96811254 |
| 87 | MP0002736_abnormal_nociception_after | 0.96457521 |
| 88 | MP0000955_abnormal_spinal_cord | 0.96389846 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 0.95660863 |
| 90 | MP0008569_lethality_at_weaning | 0.95407114 |
| 91 | MP0002735_abnormal_chemical_nociception | 0.95229802 |
| 92 | MP0001984_abnormal_olfaction | 0.95157460 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.94744202 |
| 94 | MP0001905_abnormal_dopamine_level | 0.92688836 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.92313035 |
| 96 | MP0003123_paternal_imprinting | 0.91038085 |
| 97 | MP0001970_abnormal_pain_threshold | 0.90752392 |
| 98 | MP0008872_abnormal_physiological_respon | 0.90488881 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.90484846 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.89855402 |
| 101 | MP0002572_abnormal_emotion/affect_behav | 0.88960337 |
| 102 | MP0003879_abnormal_hair_cell | 0.86797957 |
| 103 | MP0002272_abnormal_nervous_system | 0.86662495 |
| 104 | MP0003119_abnormal_digestive_system | 0.85343182 |
| 105 | MP0003953_abnormal_hormone_level | 0.85254361 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.85017232 |
| 107 | MP0003631_nervous_system_phenotype | 0.84942363 |
| 108 | MP0002184_abnormal_innervation | 0.84500492 |
| 109 | MP0006292_abnormal_olfactory_placode | 0.84347326 |
| 110 | MP0002882_abnormal_neuron_morphology | 0.84119373 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.83988651 |
| 112 | MP0006072_abnormal_retinal_apoptosis | 0.83898599 |
| 113 | MP0000026_abnormal_inner_ear | 0.83880070 |
| 114 | MP0001177_atelectasis | 0.83475699 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.82833039 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.82617306 |
| 117 | MP0004272_abnormal_basement_membrane | 0.81893676 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.81437850 |
| 119 | MP0002102_abnormal_ear_morphology | 0.80935965 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.80891566 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.79370254 |
| 122 | MP0001661_extended_life_span | 0.78218928 |
| 123 | MP0002970_abnormal_white_adipose | 0.77918053 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.77528549 |
| 125 | MP0002822_catalepsy | 0.77522714 |
| 126 | MP0001440_abnormal_grooming_behavior | 0.76299799 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.75722678 |
| 128 | MP0002152_abnormal_brain_morphology | 0.74647329 |
| 129 | MP0000647_abnormal_sebaceous_gland | 0.73830206 |
| 130 | MP0001293_anophthalmia | 0.72998548 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.72994424 |
| 132 | MP0003075_altered_response_to | 0.72106986 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.71998129 |
| 134 | MP0003646_muscle_fatigue | 0.70774319 |
| 135 | MP0005452_abnormal_adipose_tissue | 0.68175290 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.66905312 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.65048517 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.64825400 |
| 139 | MP0009697_abnormal_copulation | 0.63758957 |
| 140 | MP0003959_abnormal_lean_body | 0.63679557 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.61756505 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.61315952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.10542546 |
| 2 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.70280517 |
| 3 | Abnormality of glycine metabolism (HP:0010895) | 4.70280517 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.27684755 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.09506700 |
| 6 | Hyperammonemia (HP:0001987) | 4.06240274 |
| 7 | Xanthomatosis (HP:0000991) | 4.05626660 |
| 8 | Ketosis (HP:0001946) | 4.05343767 |
| 9 | Ketoacidosis (HP:0001993) | 4.02719112 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.96548636 |
| 11 | Hyperglycinemia (HP:0002154) | 3.87808647 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.76217973 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.39099830 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23497071 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22206303 |
| 16 | Epidermoid cyst (HP:0200040) | 3.18611481 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.09628108 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.04986302 |
| 19 | Hemorrhage of the eye (HP:0011885) | 3.00395819 |
| 20 | Complement deficiency (HP:0004431) | 2.97567299 |
| 21 | Hypolipoproteinemia (HP:0010981) | 2.95890306 |
| 22 | Hypoglycemic seizures (HP:0002173) | 2.90283016 |
| 23 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87590826 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.84640457 |
| 25 | Delayed CNS myelination (HP:0002188) | 2.80307547 |
| 26 | Gout (HP:0001997) | 2.78491337 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 2.76013489 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76013489 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 2.75031911 |
| 30 | Hyperventilation (HP:0002883) | 2.73030687 |
| 31 | Limb dystonia (HP:0002451) | 2.72547534 |
| 32 | Metabolic acidosis (HP:0001942) | 2.71666199 |
| 33 | Oligomenorrhea (HP:0000876) | 2.65695068 |
| 34 | Hydroxyprolinuria (HP:0003080) | 2.62986164 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 2.62986164 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.60733686 |
| 37 | Focal seizures (HP:0007359) | 2.60270990 |
| 38 | Abnormality of purine metabolism (HP:0004352) | 2.59170128 |
| 39 | Hemiparesis (HP:0001269) | 2.55570088 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.52988838 |
| 41 | Increased serum pyruvate (HP:0003542) | 2.49515659 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.47226955 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45861133 |
| 44 | Acanthocytosis (HP:0001927) | 2.43028807 |
| 45 | Sensorimotor neuropathy (HP:0007141) | 2.42387309 |
| 46 | Poikilocytosis (HP:0004447) | 2.42065335 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.42055442 |
| 48 | Lethargy (HP:0001254) | 2.40192661 |
| 49 | Hypertriglyceridemia (HP:0002155) | 2.38402656 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37420421 |
| 51 | Status epilepticus (HP:0002133) | 2.35122460 |
| 52 | Cholelithiasis (HP:0001081) | 2.34170425 |
| 53 | Abnormal gallbladder morphology (HP:0012437) | 2.33417433 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.31445335 |
| 55 | Gait imbalance (HP:0002141) | 2.31322636 |
| 56 | Myoglobinuria (HP:0002913) | 2.28394774 |
| 57 | Potter facies (HP:0002009) | 2.28361687 |
| 58 | Facial shape deformation (HP:0011334) | 2.28361687 |
| 59 | Abnormality of glycolysis (HP:0004366) | 2.26309072 |
| 60 | Vaginal atresia (HP:0000148) | 2.24623619 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.22202124 |
| 62 | Genital tract atresia (HP:0001827) | 2.22125826 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21328676 |
| 64 | Enlarged kidneys (HP:0000105) | 2.19325550 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.18664939 |
| 66 | Abnormal eating behavior (HP:0100738) | 2.17808530 |
| 67 | Vomiting (HP:0002013) | 2.17564032 |
| 68 | True hermaphroditism (HP:0010459) | 2.17432204 |
| 69 | Megalencephaly (HP:0001355) | 2.15226330 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.15196968 |
| 71 | Increased purine levels (HP:0004368) | 2.13436468 |
| 72 | Hyperuricemia (HP:0002149) | 2.13436468 |
| 73 | Late onset (HP:0003584) | 2.11959348 |
| 74 | Confusion (HP:0001289) | 2.11259679 |
| 75 | Hypokalemic alkalosis (HP:0001949) | 2.10983780 |
| 76 | Cholecystitis (HP:0001082) | 2.10960934 |
| 77 | Abnormal gallbladder physiology (HP:0012438) | 2.10960934 |
| 78 | Proximal tubulopathy (HP:0000114) | 2.09792827 |
| 79 | Symptomatic seizures (HP:0011145) | 2.08920815 |
| 80 | Acanthosis nigricans (HP:0000956) | 2.08466688 |
| 81 | Methylmalonic aciduria (HP:0012120) | 2.08408517 |
| 82 | Fat malabsorption (HP:0002630) | 2.07992970 |
| 83 | Increased circulating renin level (HP:0000848) | 2.06783632 |
| 84 | Metabolic alkalosis (HP:0200114) | 2.05703212 |
| 85 | Cerebral edema (HP:0002181) | 2.05605553 |
| 86 | Renal tubular acidosis (HP:0001947) | 2.02937135 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.01208777 |
| 88 | Pheochromocytoma (HP:0002666) | 2.00044508 |
| 89 | Focal motor seizures (HP:0011153) | 2.00018398 |
| 90 | Anxiety (HP:0000739) | 1.99034837 |
| 91 | Prominent supraorbital ridges (HP:0000336) | 1.97761258 |
| 92 | Increased muscle lipid content (HP:0009058) | 1.95208646 |
| 93 | Hepatoblastoma (HP:0002884) | 1.93414937 |
| 94 | Generalized tonic-clonic seizures (HP:0002069) | 1.92944224 |
| 95 | Intention tremor (HP:0002080) | 1.92134079 |
| 96 | Vascular calcification (HP:0004934) | 1.92055286 |
| 97 | Clumsiness (HP:0002312) | 1.91934313 |
| 98 | Alkalosis (HP:0001948) | 1.90489249 |
| 99 | Enlarged penis (HP:0000040) | 1.90155523 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 1.88793727 |
| 101 | Nausea (HP:0002018) | 1.87808616 |
| 102 | Irritability (HP:0000737) | 1.87362145 |
| 103 | Renal hypoplasia (HP:0000089) | 1.87326812 |
| 104 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85987641 |
| 105 | Intestinal atresia (HP:0011100) | 1.85875185 |
| 106 | Dysdiadochokinesis (HP:0002075) | 1.85487370 |
| 107 | Abnormality of the labia minora (HP:0012880) | 1.83892900 |
| 108 | Large for gestational age (HP:0001520) | 1.83500789 |
| 109 | Methylmalonic acidemia (HP:0002912) | 1.82810809 |
| 110 | Polyphagia (HP:0002591) | 1.82326493 |
| 111 | Febrile seizures (HP:0002373) | 1.81117071 |
| 112 | Abnormality of the lower motor neuron (HP:0002366) | 1.80866776 |
| 113 | Myokymia (HP:0002411) | 1.80428127 |
| 114 | Retinal atrophy (HP:0001105) | 1.80398077 |
| 115 | Skin nodule (HP:0200036) | 1.80063905 |
| 116 | Bile duct proliferation (HP:0001408) | 1.79699870 |
| 117 | Abnormal biliary tract physiology (HP:0012439) | 1.79699870 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79597905 |
| 119 | Abnormal urine output (HP:0012590) | 1.79433012 |
| 120 | Action tremor (HP:0002345) | 1.78990479 |
| 121 | Drooling (HP:0002307) | 1.78787931 |
| 122 | Nephronophthisis (HP:0000090) | 1.78046543 |
| 123 | Pancreatitis (HP:0001733) | 1.77478169 |
| 124 | Abnormality of the gallbladder (HP:0005264) | 1.77427545 |
| 125 | Hypochromic microcytic anemia (HP:0004840) | 1.77189449 |
| 126 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.75457834 |
| 127 | Abnormality of alanine metabolism (HP:0010916) | 1.73233717 |
| 128 | Hyperalaninemia (HP:0003348) | 1.73233717 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73233717 |
| 130 | Pancreatic fibrosis (HP:0100732) | 1.73211607 |
| 131 | Septo-optic dysplasia (HP:0100842) | 1.72269041 |
| 132 | Abnormality of midbrain morphology (HP:0002418) | 1.71312766 |
| 133 | Molar tooth sign on MRI (HP:0002419) | 1.71312766 |
| 134 | Poor suck (HP:0002033) | 1.70341864 |
| 135 | Epileptiform EEG discharges (HP:0011182) | 1.67747731 |
| 136 | Anophthalmia (HP:0000528) | 1.66953546 |
| 137 | Amblyopia (HP:0000646) | 1.62483619 |
| 138 | Dialeptic seizures (HP:0011146) | 1.62482839 |
| 139 | Acute encephalopathy (HP:0006846) | 1.62058219 |
| 140 | Abnormality of the vitreous humor (HP:0004327) | 1.61863392 |
| 141 | Hypsarrhythmia (HP:0002521) | 1.60043409 |
| 142 | Progressive macrocephaly (HP:0004481) | 1.59564469 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 1.59458690 |
| 144 | Glycosuria (HP:0003076) | 1.59458690 |
| 145 | Pancreatic cysts (HP:0001737) | 1.59402790 |
| 146 | Epileptic encephalopathy (HP:0200134) | 1.59119775 |
| 147 | EEG with generalized epileptiform discharges (HP:0011198) | 1.58767355 |
| 148 | Atonic seizures (HP:0010819) | 1.58205767 |
| 149 | Acute necrotizing encephalopathy (HP:0006965) | 1.57243124 |
| 150 | Bicornuate uterus (HP:0000813) | 1.57211253 |
| 151 | Abnormal sex determination (HP:0012244) | 1.55296841 |
| 152 | Sex reversal (HP:0012245) | 1.55296841 |
| 153 | Pachygyria (HP:0001302) | 1.54915703 |
| 154 | Progressive cerebellar ataxia (HP:0002073) | 1.54887559 |
| 155 | Occipital encephalocele (HP:0002085) | 1.53422090 |
| 156 | Abnormality of vitamin metabolism (HP:0100508) | 1.52858451 |
| 157 | Hypothermia (HP:0002045) | 1.51253433 |
| 158 | Hepatic necrosis (HP:0002605) | 1.51201345 |
| 159 | Broad-based gait (HP:0002136) | 1.50398444 |
| 160 | Specific learning disability (HP:0001328) | 1.49999141 |
| 161 | Sclerocornea (HP:0000647) | 1.49035349 |
| 162 | Renal cortical cysts (HP:0000803) | 1.48783587 |
| 163 | Coronal craniosynostosis (HP:0004440) | 1.48574131 |
| 164 | Bronchomalacia (HP:0002780) | 1.48421245 |
| 165 | Broad foot (HP:0001769) | 1.48133751 |
| 166 | Spastic tetraplegia (HP:0002510) | 1.47777717 |
| 167 | Pigmentary retinal degeneration (HP:0001146) | 1.47744018 |
| 168 | Absence seizures (HP:0002121) | 1.46947455 |
| 169 | Poor coordination (HP:0002370) | 1.45163781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.37136989 |
| 2 | BCKDK | 3.53346154 |
| 3 | CAMK1D | 3.10301495 |
| 4 | CAMK1G | 2.77468070 |
| 5 | SIK1 | 2.69850069 |
| 6 | LMTK2 | 2.67953622 |
| 7 | EPHB2 | 2.45729527 |
| 8 | EPHA4 | 2.34288447 |
| 9 | SGK223 | 2.24917920 |
| 10 | SGK494 | 2.24917920 |
| 11 | SGK2 | 2.21854682 |
| 12 | PINK1 | 2.09237500 |
| 13 | PDK3 | 2.04148107 |
| 14 | PDK4 | 2.04148107 |
| 15 | PNCK | 2.01534840 |
| 16 | SGK3 | 2.00641076 |
| 17 | PRKD3 | 1.99389941 |
| 18 | MAP4K2 | 1.80860238 |
| 19 | NTRK2 | 1.76312056 |
| 20 | INSRR | 1.74413988 |
| 21 | WNK3 | 1.73618063 |
| 22 | NTRK3 | 1.70386735 |
| 23 | BMPR1B | 1.67645722 |
| 24 | PHKG2 | 1.65925178 |
| 25 | PHKG1 | 1.65925178 |
| 26 | CASK | 1.62656350 |
| 27 | WNK4 | 1.59372268 |
| 28 | MAP2K4 | 1.47625382 |
| 29 | MST1R | 1.43013319 |
| 30 | MAP3K4 | 1.42917262 |
| 31 | DAPK2 | 1.42053361 |
| 32 | OXSR1 | 1.35550628 |
| 33 | LATS1 | 1.35164835 |
| 34 | MAPK13 | 1.32725721 |
| 35 | PRKAA2 | 1.22886063 |
| 36 | DYRK2 | 1.16561897 |
| 37 | PAK6 | 1.15491221 |
| 38 | LATS2 | 1.14205907 |
| 39 | UHMK1 | 1.12600285 |
| 40 | NTRK1 | 1.07736991 |
| 41 | TYRO3 | 1.06613031 |
| 42 | STK38L | 1.06145064 |
| 43 | PDPK1 | 1.06100356 |
| 44 | FRK | 1.05759825 |
| 45 | MAP2K7 | 1.04885498 |
| 46 | CAMKK1 | 1.02650882 |
| 47 | MAP3K9 | 1.01993404 |
| 48 | PRKAA1 | 1.01527049 |
| 49 | MAPK15 | 1.01400351 |
| 50 | MINK1 | 1.00460178 |
| 51 | MAP3K2 | 0.90650945 |
| 52 | STK39 | 0.89585764 |
| 53 | FGFR2 | 0.88034764 |
| 54 | PDK2 | 0.86844430 |
| 55 | CDK5 | 0.86540639 |
| 56 | PDK1 | 0.85771541 |
| 57 | ACVR1B | 0.84716990 |
| 58 | BCR | 0.84716951 |
| 59 | RIPK1 | 0.78962109 |
| 60 | MUSK | 0.77941044 |
| 61 | TSSK6 | 0.77580844 |
| 62 | PRKACG | 0.77380171 |
| 63 | CAMKK2 | 0.75779606 |
| 64 | SGK1 | 0.74648613 |
| 65 | LIMK1 | 0.74484519 |
| 66 | CAMK2D | 0.74243646 |
| 67 | EPHA3 | 0.73892271 |
| 68 | STK38 | 0.73641825 |
| 69 | ERN1 | 0.73362380 |
| 70 | LRRK2 | 0.72361195 |
| 71 | MAP2K1 | 0.72227579 |
| 72 | CAMK1 | 0.71961146 |
| 73 | TRIM28 | 0.71852528 |
| 74 | CSNK1G3 | 0.71723507 |
| 75 | PTK2B | 0.71153073 |
| 76 | PRKCG | 0.70424910 |
| 77 | GRK5 | 0.69143163 |
| 78 | MARK1 | 0.67486680 |
| 79 | KSR2 | 0.66767154 |
| 80 | ABL2 | 0.65463277 |
| 81 | TIE1 | 0.64702396 |
| 82 | MKNK2 | 0.64630556 |
| 83 | GRK6 | 0.64459737 |
| 84 | TGFBR1 | 0.64420086 |
| 85 | WNK1 | 0.61948851 |
| 86 | ADRBK2 | 0.61029876 |
| 87 | FGFR4 | 0.60626068 |
| 88 | RET | 0.60462440 |
| 89 | CDK9 | 0.60132217 |
| 90 | PLK2 | 0.59096661 |
| 91 | FER | 0.58697866 |
| 92 | CAMK2G | 0.57632893 |
| 93 | PRKCH | 0.56449089 |
| 94 | RPS6KB1 | 0.55906536 |
| 95 | PRKCZ | 0.55725109 |
| 96 | PIK3CA | 0.55540093 |
| 97 | CSNK1A1L | 0.54575677 |
| 98 | MAPK11 | 0.53840916 |
| 99 | PRKCQ | 0.53785348 |
| 100 | TNK2 | 0.53671176 |
| 101 | NLK | 0.53630884 |
| 102 | MAP3K7 | 0.53530506 |
| 103 | ERBB4 | 0.52875764 |
| 104 | MAPK12 | 0.52725315 |
| 105 | MET | 0.51753239 |
| 106 | DYRK1A | 0.51536558 |
| 107 | ERBB2 | 0.51447014 |
| 108 | CSNK1G2 | 0.51285932 |
| 109 | CSNK1E | 0.50292034 |
| 110 | CAMK2A | 0.50228847 |
| 111 | ERBB3 | 0.50119791 |
| 112 | PRKCE | 0.50028211 |
| 113 | ROCK2 | 0.49879829 |
| 114 | RPS6KA3 | 0.49588212 |
| 115 | FGFR1 | 0.49229680 |
| 116 | TESK1 | 0.49043846 |
| 117 | STK11 | 0.48881193 |
| 118 | GRK1 | 0.48758073 |
| 119 | PKN1 | 0.48482310 |
| 120 | TNIK | 0.48227902 |
| 121 | PTK2 | 0.47944156 |
| 122 | PRKG2 | 0.47897094 |
| 123 | PLK3 | 0.47285125 |
| 124 | CDK18 | 0.46639288 |
| 125 | CSNK1A1 | 0.46189367 |
| 126 | MAP3K12 | 0.46019380 |
| 127 | CDK15 | 0.45845654 |
| 128 | PTK6 | 0.45425742 |
| 129 | PRKACB | 0.45365679 |
| 130 | CAMK2B | 0.44849866 |
| 131 | ROCK1 | 0.44701274 |
| 132 | PRKG1 | 0.44242558 |
| 133 | PRKACA | 0.43929124 |
| 134 | ARAF | 0.42781752 |
| 135 | PAK3 | 0.42066963 |
| 136 | MST4 | 0.41806849 |
| 137 | PRKCA | 0.40766390 |
| 138 | PKN2 | 0.40393918 |
| 139 | CSNK1G1 | 0.40087530 |
| 140 | PRKD1 | 0.38887525 |
| 141 | EPHB1 | 0.38171733 |
| 142 | CDK6 | 0.38153912 |
| 143 | JAK2 | 0.37014978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 6.16146740 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.84899031 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65297177 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60824585 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57056534 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53218881 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46208725 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.43035810 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36920591 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.36241723 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.35855728 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.22603492 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.13779485 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.91131427 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88701971 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86906587 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85615546 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.82007948 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76250180 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74834617 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69780617 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62501978 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57334115 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52498768 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.45124594 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42200888 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.39338947 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36595428 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34747131 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32760822 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31247973 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28891699 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.19251043 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16008780 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13696290 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11530674 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10825105 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04304773 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02166731 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95304540 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94125658 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93908930 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93554935 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91964402 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90324324 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89236587 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88184198 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87361386 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84498215 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.83981300 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83434528 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83136044 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82873047 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81514480 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79567301 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78116323 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77983832 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77939007 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.76666186 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.75196289 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73830262 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72831633 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71319954 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71299347 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69920817 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69782713 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67362653 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65804965 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64278894 |
| 70 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63966810 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61193135 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58567372 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58139625 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.57854070 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57192617 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55611187 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55590863 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54712030 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53888212 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53424637 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51779385 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50861281 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.50600477 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50492590 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50397667 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50326947 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49474322 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.48942459 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48700916 |
| 90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47253856 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47243849 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46993027 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46222904 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44436621 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44417869 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43814440 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43004041 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42853321 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41806663 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41124106 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40459390 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.40417317 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.40349451 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.39304188 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37254836 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37179533 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36882508 |
| 108 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35973177 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.35905111 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.34421546 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.33817427 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32864260 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32051795 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30428913 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30420755 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28821318 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.28510997 |
| 118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.26995284 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22568182 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22044545 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21897538 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19847849 |
| 123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19391718 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18434127 |
| 125 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16863042 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14908270 |

